Emerging combination therapies to overcome resistance in EGFR-driven tumors
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Pharmacology (medical),Pharmacology,Oncology
Reference46 articles.
1. Epidermal growth factor receptor targeting in cancer.;Mendelsohn;Semin Oncol,2006
2. Epidermal growth factor receptor: mechanisms of activation and signalling.;Jorissen;Exp Cell Res,2003
3. Somatic mutations of EGFR in colorectal cancers and glioblastomas.;Barber;N Engl J Med,2004
4. Deregulated EGFR signaling during lung cancer progression: mutations, amplicons, and autocrine loops.;Gazdar;Cancer Prev Res (Phila),2008
5. The HER family and cancer: emerging molecular mechanisms and therapeutic targets.;Sergina;Trends Mol Med,2007
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. In vivo PET Imaging of EGFR Expression: An Overview of Radiolabeled EGFR TKIs;Current Topics in Medicinal Chemistry;2022-11
2. A PET imaging approach for determining EGFR mutation status for improved lung cancer patient management;Science Translational Medicine;2018-03-07
3. Selection of non-small cell lung cancer patients for intercalated chemotherapy and tyrosine kinase inhibitors;Radiology and Oncology;2017-07-18
4. Ganoderma: insights into anticancer effects;European Journal of Cancer Prevention;2016-09
5. In vitro baselining of new pyrrolopyrimidine EGFR-TK inhibitors with Erlotinib;European Journal of Pharmaceutical Sciences;2015-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3